Gerard Evan

Gerard Evan gained his BA in Biochemistry at Oxford, his PhD in Molecular Immunology at the MRC Laboratory of Molecular Biology in Cambridge, and was an MRC postdoctoral Fellow in the laboratory of J. Michael Bishop at the University of California, San Francisco (UCSF), where he developed his abiding interest in the molecular biology of cancer.

He returned to the UK in 1984 to take up a Research Fellowship at Downing College, Cambridge, and an Assistant Professorship at the Ludwig Institute for Cancer Research. In 1988, he joined the Imperial Cancer Research Fund Laboratories in London as a Senior, then Principal, Scientist, and from 1996 to 1999 held the Royal Society's Napier Research Professorship at UCL. He was elected to EMBO in 1996, and in 1999 to Fellowship of the Academy of Medical Sciences. Later that same year, he relocated to UCSF as Gerson and Barbara Bass Bakar Distinguished Professor of Cancer Research. In 2004, he was elected to Fellowship of the Royal Society. He returned to the University of Cambridge in 2009 as Sir William Dunn Professor and Head of Biochemistry.

In May 2022, he moved to the Francis Crick Institute and was appointed Professor of Cancer Biology at King's College London. His research focuses on defining the molecular aberrations that underpin the genesis and maintenance of cancers, with particular, although not exclusive, emphasis on cancers of the pancreas, lung and liver.